Danaher dental spin-off seeks $600M in IPO

2017 01 11 18 12 12 869 Dollar Sign 400

Envista Holdings, the parent company of KaVo Kerr, Nobel Biocare, and Ormco, has filed for an initial public offering (IPO). It hopes to raise more than $600 million, according to documents filed with the U.S. Securities and Exchange Commission.

Envista is a spin-off of Danaher, which first announced the plan to take the company public in July 2018. Envista plans to sell almost 27 million shares at $21 to $24 apiece ($602.3 million is the midpoint of that range). The stock will be traded on the New York Stock Exchange under the symbol NVST.

Page 1 of 66
Next Page